ONCOLYTICS BIOTECH INC (ONCY)
About ONCOLYTICS BIOTECH INC
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$28.8M
- Total assets
- $7.6M
- Market cap
- $99.8M
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $28.7M
- Operating income
- -$28.7M
- Income tax
- $79.0K
- Net income
- -$28.8M
- EPS (basic)
- $-0.30
- EPS (diluted)
- $-0.30
Balance sheet
- Total assets
- $7.6M
- Current assets
- $6.8M
- Total liabilities
- $11.4M
- Current liabilities
- $6.1M
- Shareholders’ equity
- -$3.8M
Cash flow
- Operating cash flow
- -$20.1M
- Investing cash flow
- -$6.0K
- Financing cash flow
- $14.1M
- Net cash flow
- -$5.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $99.8M
- EPS (diluted)
- $-0.3
- Shares outstanding
- 123.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 5, 2001
Oncolytics Biotech Inc (ONCY) Stock Price
- Reported a net loss of $28.8M.
- Trading 43% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ONCOLYTICS BIOTECH INC.
Write a review
News about ONCOLYTICS BIOTECH INC
News & sentiment via Polygon.io
Oncolytics Biotech Inc: frequently asked questions
Is Oncolytics Biotech Inc an American company?
Oncolytics Biotech Inc is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Oncolytics Biotech Inc headquartered?
Oncolytics Biotech Inc is headquartered in San Diego, California, United States.
Is Oncolytics Biotech Inc publicly traded?
Yes — Oncolytics Biotech Inc is a publicly traded company. Its stock trades under the ticker symbol ONCY on the NASDAQ.
What does Oncolytics Biotech Inc do?
Oncolytics Biotech Inc is an American Pharmaceuticals company in the Health & Beauty sector.
